Return on Insights: RWE in Action in Pharma Marketing – Challenges, Examples, and Future Opportunities

While pharma has been using real-world data (RWD) to generate real-world evidence (RWE) for clinical trials, post-marketing, and R&D for decades, the emergence and applicability of RWD to the sales, marketing, and commercial side of the house is now ramping up. Many organizations are exploring the possibilities related to targeting, segmentation, sales force effectiveness, and adherence, allocating growing budgets to acquire, analyze, and visualize data.

How can pharma manufacturers leverage those resources to ensure they’re engaging HCPs and patients in a timely and precise manner? That’s where advanced analytics and execution in RWD translate into actionable insights that can drive positive outcomes. This webinar will discuss the current landscape based on recent research with pharma execs, use cases in pharma today, and future opportunities.


Meet the thought leaders

Avatar for Eze Abosi

Eze Abosi

Head, Real World Evidence Solutions, OptimizeRx
Avatar for Mark Bard

Mark Bard

Co-Founder and Managing Partner, The DHC Group
Avatar for Jill Wassil

Jill Wassil

Vice President of Marketing, miraDry, Inc.
Avatar for Jim Lefevere

Jim Lefevere

International Business Leader, Digital Partnering Solutions, Roche